The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics.

Daurat, Morgane; Nguyen, Christophe; Dominguez Gil, Sofia; Sol, Vincent; Chaleix, Vincent; Charnay, Clarence; Raehm, Laurence; El Cheikh, Khaled; Morère, Alain; Bernasconi, Michele; Timpanaro, Andrea; Garcia, Marcel; Cunin, Frédérique; Roessler, Jochen; Durand, Jean-Olivier; Gary-Bobo, Magali (2020). The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics. Biomaterials science, 8(13), pp. 3678-3684. Royal Society of Chemistry 10.1039/d0bm00586j

[img] Text
d0bm00586j.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB) | Request a copy

Porphyrin-based periodic mesoporous organosilica nanoparticles (PMO) synthesized from a large functional octatriethoxysilylated porphyrin precursor and allowing two-photon excitation photodynamic therapy (TPE-PDT) and NIR imaging were synthesized. These PMO were grafted with polyethylene glycol (PEG) moieties and an analogue of mannose 6-phosphate functionalized at the anomeric position (AMFA). AMFAs are known to efficiently target mannose 6-phosphate receptors (M6PRs) which are over-expressed in various cancers. Here, we demonstrated for the first time that M6PRs were over-expressed in rhabdomyosarcoma (RMS) cells and could be efficiently targeted with PMO-AMFA allowing TPE imaging and TPE-PDT of RMS cells. The comparison with healthy myoblasts demonstrated an absence of biological effects, suggesting a cancer cell specificity in the biomedical action observed.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie)

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Haematology/Oncology

UniBE Contributor:

Rössler, Jochen Karl

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2047-4830

Publisher:

Royal Society of Chemistry

Language:

English

Submitter:

Jochen Karl Rössler

Date Deposited:

25 Jan 2021 11:55

Last Modified:

25 Jan 2021 12:03

Publisher DOI:

10.1039/d0bm00586j

PubMed ID:

32469353

BORIS DOI:

10.48350/150736

URI:

https://boris.unibe.ch/id/eprint/150736

Actions (login required)

Edit item Edit item
Provide Feedback